Formulation and Development of Transferrin Targeted Solid Lipid Nanoparticles for Breast Cancer Therapy
Breast cancer is conventionally treated by surgery, chemotherapy and radiation therapy followed by post operational hormonal therapy. Tamoxifen citrate is a best option to treat breast cancer because its selective estrogen receptor modulation activity. Owing to its antiestrogenic action on breast as...
Main Authors: | Geeta S. Bhagwat, Rajani B. Athawale, Rajeev P. Gude, Shadab Md, Nabil A. Alhakamy, Usama A. Fahmy, Prashant Kesharwani |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.614290/full |
Similar Items
-
Novel Tamoxifen Nanoformulations for Improving Breast Cancer Treatment: Old Wine in New Bottles
by: Candace M. Day, et al.
Published: (2020-03-01) -
Tamoxifen Effects on the lipid profile in premenopausal women with Breast cancer: A follow up study
by: Zainab A. M. Ali, et al.
Published: (2018-12-01) -
The role of CtIP (RBBP8) in tamoxifen resistance and human breast cancer
by: Wu, Minhao, 1976-
Published: (2011) -
The role of CtIP (RBBP8) in tamoxifen resistance and human breast cancer
by: Wu, Minhao
Published: (2008) -
Biochemical differences between nano- and normal formulation of tamoxifen and other natural bioactive materials ameliorate breast cancer in experimental rats
by: Afaf Ezzat, et al.
Published: (2021-04-01)